We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

84 hedge funds and large institutions have $538M invested in Vera Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

11% more funds holding

Funds holding: 76 → 84 (+8)

2.44% more ownership

Funds ownership: 86.14% → 88.58% (+2.4%)

12% less capital invested

Capital invested by funds: $612M → $538M (-$73.7M)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.33%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
17
Increased
38
Reduced
15
Closed
8
Calls
$364K
Puts
–
Net Calls
+$364K
Net Calls Change
+$2M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.7M
2
WP
Woodline Partners
California
+$13.9M
3
Axa
Axa
France
+$4.65M
4
ACM
Altium Capital Management
New York
+$3.67M
5
BlackRock
BlackRock
New York
+$3.23M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.7M
2
CG
Carlyle Group
District of Columbia
-$16.8M
3
Millennium Management
Millennium Management
New York
-$5.36M
4
EP
Eversept Partners
New York
-$4.5M
5
O
OrbiMed
New York
-$4.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$2.44M +$858K +50,000 +39%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.17M +$2.71M +158,186 New
Rafferty Asset Management
28
Rafferty Asset Management
New York
$1.87M +$2.34M +136,377 New
PAMP
29
Polar Asset Management Partners
Ontario, Canada
$1.86M -$2.17M -126,600 -48%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.76M -$33.9K -1,975 -2%
SFM
31
Sphera Funds Management
Israel
$1.44M – – –
Two Sigma Investments
32
Two Sigma Investments
New York
$1.38M +$1.16M +67,361 +203%
Bank of America
33
Bank of America
North Carolina
$1.3M +$1.45M +84,457 +792%
Renaissance Technologies
34
Renaissance Technologies
New York
$1.2M +$1.5M +87,200 New
Wellington Management Group
35
Wellington Management Group
Massachusetts
$1.16M +$1.45M +84,506 New
Jane Street
36
Jane Street
New York
$1.14M +$1.25M +72,982 +727%
Barclays
37
Barclays
United Kingdom
$983K +$1.11M +64,968 +965%
Voloridge Investment Management
38
Voloridge Investment Management
Florida
$955K +$1.2M +69,671 New
DCM
39
Driehaus Capital Management
Illinois
$936K – – –
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$854K -$295K -17,178 -22%
Citigroup
41
Citigroup
New York
$787K +$812K +47,322 +470%
Swiss National Bank
42
Swiss National Bank
Switzerland
$668K +$836K +48,700 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$664K +$90.2K +5,260 +12%
CM
44
Crestline Management
Texas
$622K – – –
WMSA
45
Weiss Multi-Strategy Advisers
New York
$620K -$597K -34,808 -44%
Citadel Advisors
46
Citadel Advisors
Florida
$607K +$760K +44,294 New
UBS Group
47
UBS Group
Switzerland
$602K +$398K +23,202 +112%
TLP
48
Tri Locum Partners
New York
$596K -$1.12M -65,490 -60%
AllianceBernstein
49
AllianceBernstein
Tennessee
$470K – – –
AA
50
ALPS Advisors
Colorado
$448K +$3K +175 +0.5%
1
2
3 4

VERA Hedge Fund Activity: Q3 2023 in Review

84 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q3 2023, worth a combined $538M — down 12% from $612M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VERA positions and 8 closed out — a net gain of 9 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was State Street, adding an estimated $19.7M. The largest seller was Fidelity Investments, cutting an estimated $18.7M.

  • 84 institutional investors held Vera Therapeutics (VERA) as of Q3 2023, up from 76 in Q2 2023.
  • Funds reported $538M of Vera Therapeutics stock for Q3 2023, down 12% quarter-over-quarter.
  • 17 funds opened new Vera Therapeutics positions in Q3 2023 and 8 closed out, a net change of +9 holders.
  • The largest Vera Therapeutics buyer in Q3 2023 was State Street, an estimated $19.7M added.
  • The largest Vera Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $18.7M sold.

Based on aggregated 13F filings for Q3 2023.